CLINICAL TRIAL SUMMARY

MDACC Study No:2008-0266 (clinicaltrials.gov NCT No: NCT00832429)
Title:Sentinel Lymph Node Localization and Biopsy for Sebaceous Gland Carcinoma of the Eyelid
Principal Investigator:Bita Esmaeli
Treatment Agent:None
Study Status:Open
Study Description:The goal of this clinical research study is to use sentinel lymph node (SLN -
the lymph nodes closest to the primary tumor that are believed to be at
greatest risk for spread of the disease) mapping to find SLNs and biopsy them
to see if you have metastatic disease (cancer that has spread) that would
otherwise have not been found.

Hide details for General InformationGeneral Information

Disease Group:Eye
Phase of Study:Phase II
Treatment Agents:None
Treatment Location:Only at MDACC
Estimated Length of Stay in Houston:There is no hospital stay. Patients will be treated in outpatient basis and
released on the same day.
Supported By:N/A
Return Visit:At least every 3 months (+/- 6 weeks) during the first year, every 6 months
(+/- 6 weeks) during the 2-5th year, and as needed.
Home Care:N/A.


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Bita Esmaeli
Dept:Ophthalmology/Reconstructive & Plastic Sur
For Clinical Trial Enrollment:713-794-1247
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults